Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers

BACKGROUND: Several preclinical urinary biomarkers have been qualified and accepted by the health authorities (US Food and Drug Administration, European Medicines Agency, and Pharmaceuticals and Medical Devices Agency) for detecting drug-induced kidney injury during preclinical toxicologic testing....

Descripción completa

Detalles Bibliográficos
Autores principales: Brott, David A, Adler, Scott H, Arani, Ramin, Lovick, Susan C, Pinches, Mark, Furlong, Stephen T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928457/
https://www.ncbi.nlm.nih.gov/pubmed/24611000
http://dx.doi.org/10.2147/DDDT.S54956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928457/
https://www.ncbi.nlm.nih.gov/pubmed/24611000
http://dx.doi.org/10.2147/DDDT.S54956

Ejemplares similares